Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland

被引:31
作者
Cybulski, C. [1 ]
Lubinski, J. [1 ]
Wokolorczyk, D. [1 ]
Kuzniak, W. [1 ]
Kashyap, A. [1 ]
Sopik, V. [2 ]
Huzarski, T. [1 ]
Gronwald, J. [1 ]
Byrski, T. [1 ]
Szwiec, M. [3 ]
Jakubowska, A. [1 ]
Gorski, B. [1 ]
Debniak, T. [1 ]
Narod, S. A. [2 ,4 ]
Akbari, M. R. [2 ,4 ]
机构
[1] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland
[2] Univ Toronto, Womens Coll Hosp, Womens Coll Res, Toronto, ON, Canada
[3] Ctr Oncol, Tadeusz Koszarowski Reg, Opole, Poland
[4] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
关键词
ATM; BRCA1; BRCA2; breast cancer; BRIP; CHEK2; hereditary; mutation; PALB2; whole-exome sequencing; BARD1; MUTATIONS; NBS1; GENE; SUSCEPTIBILITY; PALB2; BRCA1; RISK; PREVALENCE; DELETION; PROTEIN; 657DEL5;
D O I
10.1111/cge.12524
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A number of genes other than BRCA1 and BRCA2 have been associated with breast cancer predisposition, and extended genetic testing panels have been proposed. It is of interest to establish the full spectrum of deleterious mutations in women with familial breast cancer. We performed whole-exome sequencing of 144 women with familial breast cancer and negative for 11 Polish founder mutations in BRCA1, CHEK2 and NBS1, and we evaluated the sequences of 12 known breast cancer susceptibility genes. A truncating mutation in a breast cancer gene was detected in 24 of 144 women (17%) with familial breast cancer. A BRCA2 mutation was detected in 12 cases, a (non-founder) BRCA1 mutation was detected in 5 cases, a PALB2 mutation was detected in 4 cases and an ATM mutation was detected in 2 cases. Polish women with familial breast cancer who are negative for founder mutations in BRCA1, CHEK2 and NBS1 should be fully screened for mutations in BRCA1, BRCA2 and PALB2. The PALB2 founder mutation c.509_519delGA should be included in the panel of Polish founder mutations.
引用
收藏
页码:366 / 370
页数:5
相关论文
共 31 条
[1]   Nijmegen BREAKAGE SYNDROME mutations and risk of breast cancer [J].
Bogdanova, Natalia ;
Feshchenko, Sergei ;
Schuermann, Peter ;
Waltes, Regina ;
Wieland, Britta ;
Hillemanns, Peter ;
Rogov, Yuri I. ;
Dammann, Olaf ;
Bremer, Michael ;
Karstens, Johann H. ;
Sohn, Christof ;
Varon, Raymonda ;
Doerk, Thilo .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (04) :802-806
[2]   Prevalence of the most frequent BRCA1 mutations in Polish population [J].
Brozek, Izabela ;
Cybulska, Celina ;
Ratajska, Magdalena ;
Piatkowska, Magdalena ;
Kluska, Anna ;
Balabas, Aneta ;
Dabrowska, Michalina ;
Nowakowska, Dorota ;
Niwinska, Anna ;
Pamula-Pilat, Jolanta ;
Tecza, Karolina ;
Pekala, Wioletta ;
Rembowska, Jolanta ;
Nowicka, Karina ;
Mosor, Maria ;
Januszkiewicz-Lewandowska, Danuta ;
Rachtan, Jadwiga ;
Grzybowska, Ewa ;
Nowak, Jerzy ;
Steffen, Jan ;
Limon, Janusz .
JOURNAL OF APPLIED GENETICS, 2011, 52 (03) :325-330
[3]   Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer [J].
Casadei, Silvia ;
Norquist, Barbara M. ;
Walsh, Tom ;
Stray, Sunday ;
Mandell, Jessica B. ;
Lee, Ming K. ;
Stamatoyannopoulos, John A. ;
King, Mary-Claire .
CANCER RESEARCH, 2011, 71 (06) :2222-2229
[4]   The Validation and Clinical Implementation of BRCAplus: A Comprehensive High-Risk Breast Cancer Diagnostic Assay [J].
Chong, Hansook Kim ;
Wang, Tao ;
Lu, Hsiao-Mei ;
Seidler, Sara ;
Lu, Hong ;
Keiles, Steven ;
Chao, Elizabeth C. ;
Stuenkel, A. J. ;
Li, Xiang ;
Elliott, Aaron M. .
PLOS ONE, 2014, 9 (05)
[5]   A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland [J].
Cybulski, Cezary ;
Wokolorczyk, Dominika ;
Huzarski, Tomasz ;
Byrski, Tomasz ;
Gronwald, Jacek ;
Gorski, Bohdan ;
Debniak, Tadeusz ;
Masojc, Bartlomiej ;
Jakubowska, Anna ;
van de Wetering, Thierry ;
Narod, Steven A. ;
Lubinski, Jan .
BREAST CANCER RESEARCH AND TREATMENT, 2007, 102 (01) :119-122
[6]   A novel germline PALB2 deletion in Polish breast and ovarian cancer patients [J].
Dansonka-Mieszkowska, Agnieszka ;
Kluska, Anna ;
Moes, Joanna ;
Dabrowska, Michalina ;
Nowakowska, Dorota ;
Niwinska, Anna ;
Derlatka, Pawel ;
Cendrowski, Krzysztof ;
Kupryjanczyk, Jolanta .
BMC MEDICAL GENETICS, 2010, 11
[7]   Cancer Predisposing Missense and Protein Truncating BARD1 Mutations in Non-BRCA1 or BRCA2 Breast Cancer Families [J].
De Brakeleer, Sylvia ;
De Greve, Jacques ;
Loris, Remy ;
Janin, Nicolas ;
Lissens, Willy ;
Sermijn, Erica ;
Teugels, Erik .
HUMAN MUTATION, 2010, 31 (03) :E1175-E1185
[8]   Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations [J].
Gonzalez, Kelly D. ;
Noltner, Katie A. ;
Buzin, Carolyn H. ;
Gu, Dongqing ;
Wen-Fong, Cindy Y. ;
Nguyen, Vu Q. ;
Han, Jennifer H. ;
Lowstuter, Katrina ;
Longmate, Jeffrey ;
Sommer, Steve S. ;
Weitzel, Jeffrey N. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1250-1256
[9]   Breast cancer predisposing alleles in Poland [J].
Górski, B ;
Cybulski, C ;
Huzarski, T ;
Byrski, T ;
Gronwald, J ;
Jakubowska, A ;
Stawicka, M ;
Gozdecka-Grodecka, S ;
Szwiec, M ;
Urbañski, K ;
Mitus, J ;
Marczyk, E ;
Dziuba, J ;
Wandzel, P ;
Surdyka, D ;
Haus, O ;
Janiszewska, H ;
Debniak, T ;
Toloczko-Grabarek, A ;
Medrek, K ;
Masojc, B ;
Mierzejewski, M ;
Kowalska, E ;
Narod, SA ;
Lubinski, J .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (01) :19-24
[10]   Germline 657del5 mutation in the NBS1 gene in breast cancer patients [J].
Górski, B ;
Debniak, T ;
Masoic, B ;
Mierzejewski, M ;
Medrek, K ;
Cybulski, C ;
Jakubowska, A ;
Kurzawski, G ;
Chosia, M ;
Scott, R ;
Lubinski, J .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (03) :379-381